Healthcare technology startups across the GCC attracted $148 million in disclosed investment between January 2025 and July 2026, with Saudi Arabia accounting for more than half of the funded companies as regional interest expands from digital health services toward AI, biotechnology and precision medicine.
PitchBook data shows that 32 healthtech companies across five GCC markets secured funding during the period.
Saudi Arabia led both deal volume and capital raised, with 17 of the 32 funded companies based in the Kingdom. The UAE followed with 11 companies.
Investment trends and the next stage of regional healthtech development will be among the themes at WHX Tech, scheduled for January 26 to 28, 2027 at Dubai World Trade Centre.
Saudi Arabia leads regional healthtech funding activity
Healthtech investment remained active across 2025 and the first half of 2026.
According to the PitchBook figures cited by WHX Tech, 21 transactions closed during 2025, followed by another 11 in the first half of 2026.
Investment has covered areas including digital health, telehealth, women's health and AI-powered diagnostics.
The figures point to an ecosystem that remains relatively concentrated. Saudi Arabia and the UAE together accounted for 28 of the 32 companies receiving disclosed funding across the five GCC markets covered by the data.
The source does not provide individual investment totals for Saudi Arabia and the UAE, nor does it identify the other three GCC markets represented in the dataset.
Investment focus expands toward biotech and precision medicine
Investors are also looking beyond the digitisation of existing healthcare services toward technologies capable of generating new biological and clinical insights.
Tugce Ergul, Founding Partner of Hypernova Capital, said the GCC is beginning to shift from primarily purchasing healthcare innovation developed elsewhere toward building technologies and capabilities within the region.
She highlighted Abu Dhabi's growing capabilities in genomics, precision medicine, clinical research and health data, alongside Saudi Arabia's ambitions around vaccines, biologics manufacturing and pharmaceutical localisation.
For biotechnology companies in particular, access to capital represents only one component of the ecosystem.
Clinical data, patients, laboratories, researchers, healthcare institutions, manufacturing capacity and regulators must also be connected if companies are to move technologies from research into clinical and commercial use.
AI moves deeper into biology and diagnostics
Artificial intelligence is becoming another important component of the regional healthtech investment proposition.
Rather than simply using AI to automate administrative healthcare processes, investors are increasingly examining its potential to analyse biological information, improve prediction and accelerate scientific discovery.
One example highlighted ahead of WHX Tech is Canadian digital health startup BioTwin.
The company is working with Cleveland Clinic Abu Dhabi on pilots involving virtual human twin technology, creating individual patient profiles for breast cancer screening.
The example illustrates the increasing convergence of AI, healthcare data and clinical applications, although the source does not provide results from the pilots or evidence of their clinical performance.
GCC offers faster route to institutional pilots
Access to healthcare institutions and government-backed programmes is emerging as one of the GCC's potential advantages for healthtech startups.
Danielle Brewin Graham, General Partner at Phoenix Fire Ventures and Co-Founder of The Firehood, said regulatory sandboxes and government-backed initiatives can enable companies to pilot technologies with institutional partners more quickly than in markets where healthcare procurement and validation processes can take considerably longer.
That can be particularly valuable for startups that require access to clinical environments before demonstrating whether their technology can operate effectively at scale.
However, moving from a successful pilot to a regional business remains more complicated.
Companies expanding across the GCC must navigate different regulatory and cultural environments while developing relationships with healthcare providers, government bodies and other institutional stakeholders.
Mid-stage funding emerges as ecosystem gap
Despite increasing early-stage investment and government support, access to later rounds of capital remains a challenge for the developing healthtech ecosystem.
Brewin Graham identified mid-stage funding and the availability of experienced mentors as areas requiring further development.
While startups can benefit from early government support and investor enthusiasm, fewer regional operators have experience taking healthtech companies through Series A and subsequent stages of commercial expansion.
That gap becomes particularly important in healthcare, where companies may face lengthy clinical validation, regulatory approval and institutional sales cycles before reaching meaningful scale.
Bringing experienced operators into the ecosystem and combining that expertise with local capital and government relationships could help more companies progress beyond early-stage funding.
WHX Tech targets investor and startup connections
Healthtech investment will form a major part of WHX Tech 2027 through its Investor Programme and Xcelerate Startup Competition.
The initiatives are designed to connect emerging companies with investors, healthcare decision-makers, technology partners and industry expertise.
Participants in the Xcelerate competition will present technologies and business models spanning digital health and other healthcare technology applications.
WHX Tech will focus more broadly on data and AI, cybersecurity, connected care applications and digital health services.
Organisers expect the event to bring together more than 5,000 digital health professionals, over 200 brands and 200 speakers, with participants from more than 30 countries.
The event forms part of World Healthcare Week alongside WHX and WHX Leaders in Dubai.
Source: MEA Tech Watch Press Reporter
